MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00345-018-2427-z

Медицинская библиотека · World journal of urology · 2018

External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.

Marconi Lorenzo, de Bruijn Roderick, van Werkhoven Erik, Beisland Christian, Fife Kate, Heidenreich Axel, Kapoor Anil, Karam Jose, Kauffmann Caroline, Klatte Tobias, Ljungberg Boerje, Matin Surena, Sjoberg Daniel, Staehler Michael, Stewart Grant D, Tanguay Simon, Uzzo Robert, Welsh Sarah, Wood Lori, Wood Chris, Bex Axel

СтатьяВалидационное исследованиеПеревод в очереди

Аннотация

INTRODUCTION

Recent trials have emphasized the importance of a precise patient selection for cytoreductive nephrectomy (CN). In 2013, a nomogram was developed for pre- and postoperative prediction of the probability of death (PoD) after CN in patients with metastatic renal cell carcinoma. To date, the single-institutional nomogram which included mostly patients from the cytokine era has not been externally validated. Our objective is to validate the predictive model in contemporary patients in the targeted therapy era.

METHODS

Multi-institutional European and North American data from patients who underwent CN between 2006 and 2013 were used for external validation. Variables evaluated included preoperative serum albumin and lactate dehydrogenase levels, intraoperative blood transfusions (yes/no) and postoperative pathologic stage (primary tumour and nodes). In addition, patient characteristics and MSKCC risk factors were collected. Using the original calibration indices and quantiles of the distribution of predictions, Kaplan-Meier estimates and calibration plots of observed versus predicted PoD were calculated. For the preoperative model a decision curve analysis (DCA) was performed.

RESULTS

Of 1108 patients [median OS of 27 months (95% CI 24.6-29.4)], 536 and 469 patients had full data for the validation of the pre- and postoperative models, respectively. The AUC for the pre- and postoperative model was 0.68 (95% CI 0.62-0.74) and 0.73 (95% CI 0.68-0.78), respectively. In the DCA the preoperative model performs well within threshold survival probabilities of 20-50%. Most important limitation was the retrospective collection of this external validation dataset.

CONCLUSIONS

In this external validation, the pre- and postoperative nomograms predicting PoD following CN were well calibrated. Although performance of the preoperative nomogram was lower than in the internal validation, it retains the ability to predict early death after CN.

Для цитирования: Marconi Lorenzo, de Bruijn Roderick, van Werkhoven Erik, Beisland Christian, Fife Kate, Heidenreich Axel, Kapoor Anil, Karam Jose, Kauffmann Caroline, Klatte Tobias, Ljungberg Boerje, Matin Surena, Sjoberg Daniel, Staehler Michael, Stewart Grant D, Tanguay Simon, Uzzo Robert, Welsh Sarah, Wood Lori, Wood Chris, Bex Axel. External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.. World journal of urology. 2018. DOI: 10.1007/s00345-018-2427-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.